Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Biologics Hot Titles 2025
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services
Recreation Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare
Mega Trends
3D Printing 5G and 6G Technologies Advanced Analytics and Predictive Analytics Alternative Proteins (Plant-Based, Cultured Meat) Artificial Intelligence (AI) Autonomous Systems Augmented Reality (AR) and Virtual Reality (VR) Big Data Analytics
Blockchain, Cryptocurrencies and Decentralized Finance (DeFi) Biotechnology Cloud Computing Cybersecurity Digital Therapeutics Digitalization E-commerce and Digital Retail Edtech and E-Learning
Electric Mobility ESG (Environmental, Social, Governance) Investments Fintech (Digital Payments, Neobanking, Open Banking) Healthtech and Telehealth Industry 4.0 and 5.0 Internet of Things (IoT) Nanotechnology Precision Medicine and Genomics
Quantum Computing Regtech and Insurtech Robotics Smart Homes and Buildings Space Economy Sustainability Sustainable Consumer Products Wearable Technology
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Global Tumor Models Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Global Tumor Models Market Report 2025

Tumor Models Global Market Report 2025 - By Type Of Tumor (Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models), By Application (Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies ), By Technology (Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models ), By End-User (Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations) - Market Size, Trends, And Global Forecast 2025-2034

Tumor Models Global Market Report 2025

Report Price : $4490.00 | Pages : 250 | Published : September 2025 | Delivery Time: 2-3 business days Info icon | Format : pdf icon

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Regional Data
FAQs
Tumor Models Global Market Report 2025
Description Table Of Contents Tables & Figures

Market Insights

Related Reports

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tumor Models Market Overview

• Tumor Models market size has reached to $1.92 billion in 2024

• Expected to grow to $3.23 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%

• Growth Driver: Growing Demand For Personalized Medicine Shaping The Market Growth Due To People Preferring Health Technologies

• Market Trend: Advancements In 3D Tumor Modeling For Improved Predictive Accuracy

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Tumor Models Market?

Tumor models are experimental biological systems created to imitate the features and behavior of tumors found in living organisms. They are structured to reflect the cellular composition, molecular traits, and growth patterns of cancer, as well as its interaction with the surrounding environment. Such models allow researchers to study tumor formation and progression in a controlled setting, supporting a deeper understanding of cancer biology.

The main types of tumor models are primary tumor models, metastatic tumor models, orthotopic tumor models, and heterotopic tumor models. Primary tumor models refer to experimental tumor models developed by implanting or inducing cancer cells at the original site where the tumor naturally arises in the body. The multiple applications involved are drug discovery and development, cancer research, personalized medicine, and toxicology studies, and it uses various technologies, including xenograft models, genetically engineered mouse models (GEMMs), three-dimensional (3D) tumor spheroids, and organ-on-a-chip models. It caters to several end users, such as pharmaceutical and biotechnology companies, academic institutions, contract research organizations (CROs), and government research organizations.

Tumor Models Market Size and growth rate 2025 to 2029: Graph
link share icon Share

What Is The Tumor Models Market Size 2025 And Growth Rate?

The tumor model market size has grown rapidly in recent years. It will grow from $1.92 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increasing cancer incidence, rising demand for personalized medicine, increasing need for better preclinical predictability, rising use of patient-derived xenograft models, and growing reliance on in vivo efficacy data.

What Is The Tumor Models Market Growth Forecast?

The tumor model market size is expected to see rapid growth in the next few years. It will grow to $3.23 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to growing focus on human-relevant models, increasing demand for precision oncology, the rise in immuno-oncology, growing demand for high-throughput screening models, expanding interest in rare cancer models, and expanding interest in rare cancer models. Major trends in the forecast period include the development of three-dimensional (3D) cell culture models, pharmaceutical research and developments, advancements in cell culture technology, the integration of AI in cancer modelling, and the development of patient-derived organoids.

chesta image

Book your 30 minutes free consultation with our research experts

Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Tumor Models Market Segmented?

1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models

2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies

3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations

Subsegments:

1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models

2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models

3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models

4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models

What Is Driving The Tumor Models Market? Growing Demand For Personalized Medicine Shaping The Market Growth Due To People Preferring Health Technologies

The growing demand for personalized medicine is expected to propel the growth of the tumor models market going forward. Personalized medicine refers to a medical model that uses information about a person’s genes and lifestyle environment to tailor treatments and healthcare to their specific needs. The rise of personalized medicine is due to people preferring health technologies that offer real-time monitoring and treatment plans customized to their unique biology. Tumor models help personalized medicine by allowing researchers and clinicians to test and predict how individual patients' tumors will respond to specific treatments as experimental platforms that mimic the behavior of real human cancers, enabling a more tailored approach to therapy. For instance, in February 2023, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the approval of 12 new personalized medicines represented approximately 34% of all newly approved therapies, indicating a substantial increase from previous years. Therefore, the growing demand for personalized medicine is driving the growth of the tumor models industry.

Who Are The Major Players In The Global Tumor Models Market?

Major companies operating in the tumor models market are Merck & Co Inc., LabCorp Holdings Inc., Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., Reaction Biology Corporation, InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH, and Hera BioLabs Inc.

What Are The Key Trends Of The Global Tumor Models Market? Advancements In 3D Tumor Modeling For Improved Predictive Accuracy

Major companies operating in the tumor models market are focusing on developing advanced solutions, such as tumor spheroid models, to enhance the physiological relevance and predictive accuracy of in vitro cancer models. Tumor spheroid models refer to three-dimensional (3D) aggregates of cancer cells that spontaneously form spherical structures in culture. For instance, in June 2024, Predictive Oncology, a US-based provider of advanced 3D cell culture technologies and predictive oncology solutions, launched novel 3D cell technology to accelerate cancer therapeutic drug discovery. It offers unique features such as advanced 3D tumor spheroid and organoid models that closely mimic the tumor microenvironment, high-throughput screening capabilities for rapid drug testing, support for patient-derived personalized tumor models, detailed analysis of drug penetration in 3D structures, and integration with AI-driven data analytics for enhanced predictive accuracy and deeper insights into therapeutic responses.

What Are Latest Mergers And Acquisitions In The Tumor Models Market? Merck And Co Inc. Acquired Modifi Biosciences To Bolster Oncology Portfolio

In October 2024, Merck & Co. Inc., a US-based pharmaceutical company, acquired Modifi Biosciences for an undisclosed amount. Through this acquisition, Merck aims to strengthen its oncology portfolio by integrating Modifi’s novel small-molecule therapies designed to selectively target cancer cells deficient in the deoxyribonucleic acid (DNA) repair with a focus on hard-to-treat tumors such as glioblastomas. Modifi Biosciences Inc. is a US-based biotechnology company that specializes in tumor models.

What Is The Regional Outlook For The Global Tumor Models Market?

North America was the largest region in the tumor models market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Tumor Models Market?

The tumor models market includes revenues earned by entities by providing services such as drug screening and efficacy testing, tumor biology research, biomarker discovery and validation, toxicology and safety testing, and immuno-oncology studies. The market value includes the value of related goods sold by the service provider or included within the service offering. The tumor models market also includes sales of cancer cell lines, in vitro tumor models, imaging systems, tumor model kits, and reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Tumor Models Industry?

The tumor models market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the tumor models industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author: Abdul Wasay

Tumor Models Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $2.13 billion
Revenue Forecast In 2034 $3.23 billion
Growth Rate CAGR of 10.9% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Type Of Tumor, Application, Technology, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck & Co Inc., LabCorp Holdings Inc., Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., Reaction Biology Corporation, InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH, and Hera BioLabs Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Tumor Models Market Characteristics

    3. Tumor Models Market Trends And Strategies

    4. Tumor Models Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

    4.1. Supply Chain Impact from Tariff War & Trade Protectionism

    5. Global Tumor Models Growth Analysis And Strategic Analysis Framework

    5.1. Global Tumor Models PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Tumor Models Market Growth Rate Analysis

    5.4. Global Tumor Models Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Tumor Models Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Tumor Models Total Addressable Market (TAM)

    6. Tumor Models Market Segmentation

    6.1. Global Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Primary Tumor Models

    Metastatic Tumor Models

    Orthotopic Tumor Models

    Heterotopic Tumor Models

    6.2. Global Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Drug Discovery And Development

    Cancer Research

    Personalized Medicine

    Toxicology Studies

    6.3. Global Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Xenograft Models

    Genetically Engineered Mouse Models (GEMMs)

    Three-Dimensional (3D) Tumor Spheroids

    Organ-On-A-Chip Models

    6.4. Global Tumor Models Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Pharmaceutical And Biotechnology Companies

    Academic Institutions

    Contract Research Organizations (CROs)

    Government Research Organizations

    6.5. Global Tumor Models Market, Sub-Segmentation Of Primary Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Carcinoma Models

    Sarcoma Models

    Glioma Models

    Melanoma Models

    Leukemia Models

    Lymphoma Models

    6.6. Global Tumor Models Market, Sub-Segmentation Of Metastatic Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Lung Metastasis Models

    Bone Metastasis Models

    Liver Metastasis Models

    Brain Metastasis Models

    Lymph Node Metastasis Models

    6.7. Global Tumor Models Market, Sub-Segmentation Of Orthotopic Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Orthotopic Breast Cancer Models

    Orthotopic Lung Cancer Models

    Orthotopic Pancreatic Cancer Models

    Orthotopic Colon Cancer Models

    Orthotopic Prostate Cancer Models

    6.8. Global Tumor Models Market, Sub-Segmentation Of Heterotopic Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Subcutaneous Tumor Models

    Intramuscular Tumor Models

    Intraperitoneal Tumor Models

    7. Tumor Models Market Regional And Country Analysis

    7.1. Global Tumor Models Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Tumor Models Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Tumor Models Market

    8.1. Asia-Pacific Tumor Models Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Tumor Models Market

    9.1. China Tumor Models Market Overview

    9.2. China Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Tumor Models Market

    10.1. India Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Tumor Models Market

    11.1. Japan Tumor Models Market Overview

    11.2. Japan Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Tumor Models Market

    12.1. Australia Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Tumor Models Market

    13.1. Indonesia Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Tumor Models Market

    14.1. South Korea Tumor Models Market Overview

    14.2. South Korea Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Tumor Models Market

    15.1. Western Europe Tumor Models Market Overview

    15.2. Western Europe Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Tumor Models Market

    16.1. UK Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Tumor Models Market

    17.1. Germany Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Tumor Models Market

    18.1. France Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Tumor Models Market

    19.1. Italy Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Tumor Models Market

    20.1. Spain Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Tumor Models Market

    21.1. Eastern Europe Tumor Models Market Overview

    21.2. Eastern Europe Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Tumor Models Market

    22.1. Russia Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Tumor Models Market

    23.1. North America Tumor Models Market Overview

    23.2. North America Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Tumor Models Market

    24.1. USA Tumor Models Market Overview

    24.2. USA Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Tumor Models Market

    25.1. Canada Tumor Models Market Overview

    25.2. Canada Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Tumor Models Market

    26.1. South America Tumor Models Market Overview

    26.2. South America Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Tumor Models Market

    27.1. Brazil Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Tumor Models Market

    28.1. Middle East Tumor Models Market Overview

    28.2. Middle East Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Tumor Models Market

    29.1. Africa Tumor Models Market Overview

    29.2. Africa Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Tumor Models Market Competitive Landscape And Company Profiles

    30.1. Tumor Models Market Competitive Landscape

    30.2. Tumor Models Market Company Profiles

    30.2.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. LabCorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. WuXi AppTec Co Ltd. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Tumor Models Market Other Major And Innovative Companies

    31.1. PerkinElmer Inc.

    31.2. Pharmaron Beijing Co. Ltd.

    31.3. The Jackson Laboratory

    31.4. Taconic Biosciences Inc.

    31.5. Cyagen Biosciences Inc.

    31.6. Crown Bioscience Inc.

    31.7. Champions Oncology Inc.

    31.8. Reaction Biology Corporation

    31.9. InSphero AG

    31.10. Creative Biolabs Inc.

    31.11. Oncodesign S.A.

    31.12. Xentech S.A.

    31.13. MIMETAS BV

    31.14. Experimental Pharmacology and Oncology Berlin-Buch GmbH

    31.15. Hera BioLabs Inc.

    32. Global Tumor Models Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Tumor Models Market

    34. Recent Developments In The Tumor Models Market

    35. Tumor Models Market High Potential Countries, Segments and Strategies

    35.1 Tumor Models Market In 2029 - Countries Offering Most New Opportunities

    35.2 Tumor Models Market In 2029 - Segments Offering Most New Opportunities

    35.3 Tumor Models Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Tumor Models Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Tumor Models Market, Sub-Segmentation Of Primary Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Tumor Models Market, Sub-Segmentation Of Metastatic Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Tumor Models Market, Sub-Segmentation Of Orthotopic Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Tumor Models Market, Sub-Segmentation Of Heterotopic Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Tumor Models Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Tumor Models Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Merck & Co Inc. Financial Performance
  • Table 80: LabCorp Holdings Inc. Financial Performance
  • Table 81: Eurofins Scientific SE Financial Performance
  • Table 82: WuXi AppTec Co Ltd. Financial Performance
  • Table 83: Charles River Laboratories International Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Tumor Models Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Tumor Models Market, Sub-Segmentation Of Primary Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Tumor Models Market, Sub-Segmentation Of Metastatic Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Tumor Models Market, Sub-Segmentation Of Orthotopic Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Tumor Models Market, Sub-Segmentation Of Heterotopic Tumor Models, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Tumor Models Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Tumor Models Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Tumor Models Market, Segmentation By Type Of Tumor, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Tumor Models Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Tumor Models Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Merck & Co Inc. Financial Performance
  • Figure 80: LabCorp Holdings Inc. Financial Performance
  • Figure 81: Eurofins Scientific SE Financial Performance
  • Figure 82: WuXi AppTec Co Ltd. Financial Performance
  • Figure 83: Charles River Laboratories International Inc. Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Read More About Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Read More About Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Read More About Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Brain Pacemaker Global Market Report 2025 – By Type (Single Channel, Dual Channel), By Application (Dystonia, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder, Parkinson's Disease, Other Applications), By Sales Channel (Channel Sales, Direct Sales), By End-User (Hospitals, Ambulatory Surgical Centers And Clinics, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

K-12 Private Education Global Market Report 2025 – By Method (Blended And Instructor-Led Training, Computer And Web-Based Training, Text books And Self-Study Material, Video And Audio Recording, Simulation-Based training, Other Methods), By Deployment Mode (Cloud, On-Premise), By Service Providers (Ed-Tech companies, Educational Institutions, Online Courses, Other Service Providers), By Application (Pre-Primary School, Primary School, Middle School, High School, Other Applications) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Payments Global Market Report 2025 – By Type (Credit Transfer, Direct Debit, Check Payment, Cash Deposit), By Application (Banks, Non-Banking Financial Institutions, Other Applications), By End-user Industry (Retail, Banking and Financial Service, Telecommunication, Government, Transportation, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Cold Chain Temperature Monitoring Global Market Report 2025 – By Hardware (Conventional Temperature Loggers, Real Time Monitoring Devices, Resistance Temperature Detectors, Temperature Indicators, Other Hardware), By Software (On Premise, Cloud Based), By End User (Fish, Meat And Seafood, Processed Food, Pharmaceuticals, Bakery And Confectionaries, Fruits And Vegetables, Dairy Products, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Digital Logistics Global Market Report 2025 – By Component( Solution, Services ), By System( Tracking And Monitoring Systems, Information Integrated Systems, Electronic Data Interchange Systems, Database Management Systems, Fleet Management Systems, Order Management Systems ), By Deployment Mode( Cloud, On-Premises), By Application( Warehouse Management, Labor Management, Transportation Management), By End-User Industry( Government, Aerospace, Defense, Automotive, Oil And Gas, Retail, Manufacturing, Healthcare, Other End-User Industries ) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Digital Payments Global Market Report 2025 – By Mode Of Payment (Point Of Sale, Online Sale), By End-User Industry (Retail, Banking And Financial Service, Telecommunication, Government, Transportation, Others), By Deployment (Cloud, On-Premise), By Enterprise (Large Enterprises, Small And Medium Enterprises) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Teleprotection Global Market Report 2025 – By Type (Teleprotection Unit, Communication Network Technology, Telecontrol Software and Services), By Component (Intelligent Electronic Device (IED), Interface Device, Communication Network Components, Teleprotection SCADA), By Application (Power, Telecom, Information Technology, Oil and Gas Pipelines, Transportation, Aerospace and Defense, Other Applications) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Frequently Asked Questions

What is the definition of the Tumor Models market?

Tumor models are experimental biological systems created to imitate the features and behavior of tumors found in living organisms. They are structured to reflect the cellular composition, molecular traits, and growth patterns of cancer, as well as its interaction with the surrounding environment. Such models allow researchers to study tumor formation and progression in a controlled setting, supporting a deeper understanding of cancer biology. For further insights on this market, request a sample here

How will the Tumor Models market drivers and restraints affect the market dynamics? What forces will shape the Tumor Models industry going forward?

The market major growth driver - Growing Demand For Personalized Medicine Shaping The Market Growth Due To People Preferring Health Technologies. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Tumor Models market?

The tumor model market size has grown rapidly in recent years. It will grow from $1.92 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increasing cancer incidence, rising demand for personalized medicine, increasing need for better preclinical predictability, rising use of patient-derived xenograft models, and growing reliance on in vivo efficacy data. The tumor model market size is expected to see rapid growth in the next few years. It will grow to $3.23 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to growing focus on human-relevant models, increasing demand for precision oncology, the rise in immuno-oncology, growing demand for high-throughput screening models, expanding interest in rare cancer models, and expanding interest in rare cancer models. Major trends in the forecast period include the development of three-dimensional (3D) cell culture models, pharmaceutical research and developments, advancements in cell culture technology, the integration of AI in cancer modelling, and the development of patient-derived organoids. For further insights on this market, request a sample here

How is the Tumor Models market segmented?

The tumor models market covered in this report is segmented
1) By Type Of Tumor: Primary Tumor Models, Metastatic Tumor Models, Orthotopic Tumor Models, Heterotopic Tumor Models
2) By Application: Drug Discovery And Development, Cancer Research, Personalized Medicine, Toxicology Studies
3) By Technology: Xenograft Models, Genetically Engineered Mouse Models (GEMMs), Three-Dimensional (3D) Tumor Spheroids, Organ-On-A-Chip Models
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Institutions, Contract Research Organizations (CROs), Government Research Organizations Subsegments:
1) By Primary Tumor Models: Carcinoma Models, Sarcoma Models, Glioma Models, Melanoma Models, Leukemia Models, Lymphoma Models
2) By Metastatic Tumor Models: Lung Metastasis Models, Bone Metastasis Models, Liver Metastasis Models, Brain Metastasis Models, Lymph Node Metastasis Models
3) By Orthotopic Tumor Models: Orthotopic Breast Cancer Models, Orthotopic Lung Cancer Models, Orthotopic Pancreatic Cancer Models, Orthotopic Colon Cancer Models, Orthotopic Prostate Cancer Models
4) By Heterotopic Tumor Models: Subcutaneous Tumor Models, Intramuscular Tumor Models, Intraperitoneal Tumor Models For further insights on this market, request a sample here

Which region has the largest share of the Tumor Models market? What are the other regions covered in the report?

North America was the largest region in the tumor models market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor models market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Tumor Models market?

Major companies operating in the tumor models market are Merck & Co Inc., LabCorp Holdings Inc., Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Pharmaron Beijing Co. Ltd., The Jackson Laboratory, Taconic Biosciences Inc., Cyagen Biosciences Inc., Crown Bioscience Inc., Champions Oncology Inc., Reaction Biology Corporation, InSphero AG, Creative Biolabs Inc., Oncodesign S.A., Xentech S.A., MIMETAS BV, Experimental Pharmacology and Oncology Berlin-Buch GmbH, and Hera BioLabs Inc. . For further insights on this market, request a sample here.

What are the key trends in the Tumor Models market?

Major trends in this market include Advancements In 3D Tumor Modeling For Improved Predictive Accuracy. For further insights on this market, request a sample here.

Back to top
Back to top